Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French continue to challenge the status quo

This article was originally published in Clinica

Executive Summary

The French authorities continued to be active on the regulatory front during 1996, challenging what most other Member States of the European Economic Area accept. From discussions about the technical requirements for breast implants and condoms to negotiations on the content of the impending In Vitro Diagnostics Directive, France has been out of step with its European partners. The French authorities are even going against the spirit, if not the letter, of regulatory agreements by insisting on their right to request comprehensive information randomly about CE-marked products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel